BioE2E achieves its mission
through distinguished lecturers, direct education, networking events
and strong relationships with the Bay Area entrepreneurial community. Most of our monthly events occur in the evening on the first Wednesday of the month.
Here are some of our upcoming events.
| Scheduled Upcoming
Events
|
|
|
| Past Events
|
Date
|
Title
|
| Jun 4th, 2008 |
How…and When will the Business of Cell Based Therapeutics be Realized? |
| May 7th, 2008 |
Strategies for Diagnostics Companies |
| Apr 9th, 2008 |
Nutraceuticals - Heaven or Purgatory?
Getting Innovations from Human Health to Market |
| Mar 5th, 2008 |
Where's the innovation? |
| Feb 6th, 2008 |
Early Stage Drug Development, A Balance of Luck and Perseverance: Herceptin A Case Study |
| Nov 14th, 2007 |
Lifescience Opportunities in the Emerging Markets |
| Oct 29th, 2007 |
SBIR/STTR Grant Writing Workshop - Non-diultive funding to help jump-start your company |
| Sept 12th, 2007 |
Successful Strategies for Tool Companies |
| Jul 11th, 2007 |
Biofuel - Tinker Outside the Box |
| Jun 13th, 2007 |
BioE2E Summer Mixer at Cooley Godward |
| May 9th, 2007 |
Building a Corporate Culture |
| Apr 11th, 2007 |
Corporate Venture Capital Comes in Many Flavors |
| Mar 14th, 2007 |
Myelin Repair Foundation -
Revolutionizing Medical Research |
| Feb 14th, 2007 |
A Yen for Funding and Partnering |
| Jan 24th, 2007 |
Where Has All the Money Gone? |
| Dec 13th, 2006 |
No events planned |
| Nov 17th, 2006 |
November 17th, 2006
The Annual Pitch Event
California Pacific Medical Center
475 Brannan Street, San Francisco, CA |
| Oct 7th, 2006 |
The Annual Funding Fair
At Genentech Hall, UCSF Mission Bay |
| Sept 13th, 2006 |
September 13th, 2006
Creating Virtual Value – a $527 Million Buyout of Angiosyn by Pfizer |
| Aug 9th, 2006 |
The Exubera Experience: John Patton from Nektar |
| July 26th, 2006 |
Summer Mixer at Cooley Godward, Palo Alto |
| June 14th, 2006 |
The Rise of Abmaxis and the $80MM Merck Acquistion
|
| May 10th, 2006 |
Life Science Opportunities in India
|
| Apr 05, 2006 |
Non-VC Funding of Biotech Startups: Individual Investors, Private Funds, and Investing Groups ("Angels") |
| Feb 8, 2006 |
JP Morgan Healthcare Conference Review
|
| Dec 7, 2005 |
Creating New Businesses in the Wake of an "IP Mudslide"
|
| Nov 2, 2005 |
Countdown to IPO: The last month to minutes from a corporate, investment, and legal perspective
|
| Oct 7, 2005 |
Fourth Annual Alternative Funding Fair
|
| Sep 17, 2005 |
Pitch Event 2005
|
| Sep 7, 2005 |
Partnering with Universities: The Sponsored Research Agreement
|
| Jul 12, 2005 |
Fourth Annual BioE2E Summer Mixer
|
| Jul 6, 2005 |
The Kyphon Story: From Concept to Market Leader
|
| Jun 1, 2005 |
Navigating the Minefields, The Alexza Molecular Delivery Corporation Story
|
| May 4, 2005 |
Accelerate Preclinical Development: Outsourcing to China
|
| Apr 6, 2005 |
IP Due Diligence Inside the Mind of a VC
|
| Feb 1, 2005 |
Cynthia Robbins-Roth
|
| Nov 13, 2004 |
Second Annual Pitch Event (at the Buck Institute)
|
| Oct 6, 2004 |
The Intelligent Way to Join a Start-Up
|
| Sep 1, 2004 |
Make It or Break It: Early-Stage Product Deals
|
| Aug 4, 2004 |
Globalization -- Making it Work Overseas
|
| Jul 14, 2004 |
Third Annual BioE2E Summer Mixer
|
| Jul 7, 2004 |
Valuations 3.0
|
| Jun 2, 2004 |
The Art of Building High-Value Biotech Patent Portfolios
|
| May 5, 2004 |
Taking the First Steps
|
| Apr 7, 2004 |
Biotech Corporate Venture Capital
|
| Mar 3, 2004 |
Early Stage Deals Attract Investment When....
|
| Feb 27, 2004 |
Third Annual Alternative Funding Fair
|
| Feb 4, 2004 |
Minding the Gap: Early stage funding for biotechnology |
| Jan 14, 2004 |
Second Annual BioE2E CEO Reception
|
| Dec 6, 2003 |
"The Pitch" -- the first of three events in our "First Money Series"
|
| Nov 18, 2003 |
First Annual Career Fair
|
| Oct 1, 2003 |
Valuation 2.0: How to justify biotech value
|
| Sep 3, 2003 |
The Art of Partnering in Early Stage Deals - Discovery and pre-clinical/phase I stage alliances
|
| Aug 6, 2003 |
Responding to a Clinical Crisis - Media Communications in the First 24 Hours
|
| Jul 2, 2003 |
Preparing for Crisis: Learning from when things really went wrong
|
| Jun 18, 2003 |
Second Annual BioE2E Summer Mixer
|
| May 7, 2003 |
Funding Startups: Inside the Mind of VCs
|
| Apr 2, 2003 |
Business Models: What They Are, and What's Getting Funded Now
|
| Mar 5, 2003 |
FDA Regulatory Strategies
|
| Feb 28, 2003 |
Second Annual Alternative Funding Fair
|
| Feb 5, 2003 |
Homeland Security: Emerging Opportunities for Bioentrepreneurs
|
| Jan 6, 2003 |
BioE2E Winter Mixer (BioCEO Reception)
|
| Dec 4, 2002 |
Sell Yourself: Get Results
|
| Nov 6, 2002 |
Building a Positive Corporate Culture
|
| Oct 2, 2002 |
The Importance of Boards in Building a Successful Company
|
| Sep 4, 2002 |
When VCs talk about "market conditions," what do they mean? |
| Aug 7, 2002 |
Intellectual Property for the Entrepreneur
|
| Jul 18, 2002 |
BioE2E Summer Mixer
|
| Jun 5, 2002 |
Term Sheets and Closing Round A
|
| May 1, 2002 |
Navigating the Biotech/University Deal
|
| Apr 20, 2002 |
Alternative Funding Fair (Full Day Event)
|
| Apr 3, 2002 |
Financing Strategies - From 0 to Round A
|
| Mar 6, 2002 |
After Raising Money, Then What?
|
| Feb 6, 2002 |
Landing That First Partnership
|
| Jan 9, 2002 |
Life Science Corporate Landscapes & What It Means For Entrepreneurs |
| Dec 5, 2001 |
Does Your Business Plan Have A Fatal Flaw?
|
| Nov 7, 2001 |
The Evolution of Biotech Companies
|
|
|